title: The role of ghrelin in anorexia-cachexia syndromes.
abstract: Anorexia, sarcopenia, and cachexia are common complications of many chronic conditions including cancer, rheumatoid arthritis, HIV infection, aging, and chronic lung, heart, or kidney disease. Currently, there is no effective treatment for muscle atrophy or wasting conditions although they typically take a significant toll on the quality of life of patients and are associated with poor prognosis and decreased survival. Ghrelin affects multiple key pathways in the regulation of body weight, body composition, and appetite in the setting of cachexia that may lead to an increase in appetite and growth hormone secretion and a reduction in energy expenditure and inflammation. The net effect is increased lean body mass and fat mass preservation. In this chapter, we review the mechanisms of action of ghrelin and present the available data in animal models and human trials using ghrelin or ghrelin mimetics in different settings of cachexia.
authors.affiliation: Division of Diabetes, Endocrinology and Metabolism, Michael E DeBakey Veterans Affairs Medical Center, Baylor College of Medicine, Houston, Texas, USA.
authors.forename: Bobby
authors.initials: B
authors.lastname: Guillory
authors.forename: Andres
authors.initials: A
authors.lastname: Splenser
authors.forename: Jose
authors.initials: J
authors.lastname: Garcia
mesh_terms: D000818:Animals; D000855:Anorexia / Q000235:genetics / Q000378:metabolism*; D002100:Cachexia / Q000235:genetics / Q000378:metabolism*; D004734:Energy Metabolism; D005786:Gene Expression Regulation; D054439:Ghrelin / Q000235:genetics / Q000378:metabolism*; D006801:Humans
chemical_list: D054439:Ghrelin